A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

Clinical trial NCT04969835 · RECRUITING

Trial details

NCT number: NCT04969835
Sponsor: Avacta Life Sciences Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Salivary Gland Tumor Urothelial Carcinoma Ovarian Carcinoma Breast Cancer Soft Tissue Sarcoma

Start date: 2021-07-16
Primary completion: 2026-06-15
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.